Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference H Northrup, DA Krueger, S Roberds, K Smith, J Sampson, B Korf, ... Pediatric neurology 49 (4), 243-254, 2013 | 1602 | 2013 |
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis JJ Bissler, FX McCormack, LR Young, JM Elwing, G Chuck, JM Leonard, ... New England Journal of Medicine 358 (2), 140-151, 2008 | 1429 | 2008 |
Efficacy and safety of sirolimus in lymphangioleiomyomatosis FX McCormack, Y Inoue, J Moss, LG Singer, C Strange, K Nakata, ... New England Journal of Medicine 364 (17), 1595-1606, 2011 | 1165 | 2011 |
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference DA Krueger, H Northrup, S Roberds, K Smith, J Sampson, B Korf, ... Pediatric neurology 49 (4), 255-265, 2013 | 904 | 2013 |
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment JH Ryu, J Moss, GJ Beck, JC Lee, KK Brown, JT Chapman, GA Finlay, ... American journal of respiratory and critical care medicine 173 (1), 105-111, 2006 | 591 | 2006 |
The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung FX McCormack, JA Whitsett The Journal of clinical investigation 109 (6), 707-712, 2002 | 559 | 2002 |
Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability H Wu, A Kuzmenko, S Wan, L Schaffer, A Weiss, JH Fisher, KS Kim, ... The Journal of clinical investigation 111 (10), 1589-1602, 2003 | 558 | 2003 |
Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. CD Gaynor, FX Mccormack, DR Voelker, SE McGowan, LS Schlesinger Journal of immunology (Baltimore, Md.: 1950) 155 (11), 5343-5351, 1995 | 424 | 1995 |
Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4 L Guillot, V Balloy, FX McCormack, DT Golenbock, M Chignard, ... The Journal of Immunology 168 (12), 5989-5992, 2002 | 410 | 2002 |
Lymphangioleiomyomatosis: a clinical update FX McCormack Chest 133 (2), 507-516, 2008 | 408 | 2008 |
Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis TA Smolarek, LL Wessner, FX McCormack, JC Mylet, AG Menon, ... The American Journal of Human Genetics 62 (4), 810-815, 1998 | 359 | 1998 |
Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations H Northrup, ME Aronow, EM Bebin, J Bissler, TN Darling, PJ de Vries, ... Pediatric Neurology 123, 50-66, 2021 | 344 | 2021 |
Lymphangioleiomyomatosis—a wolf in sheep’s clothing EP Henske, FX McCormack The Journal of clinical investigation 122 (11), 3807-3816, 2012 | 338 | 2012 |
Surfactant protein D binds to Mycobacterium tuberculosis Bacilli and Lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by … JS Ferguson, DR Voelker, FX McCormack, LS Schlesinger The Journal of immunology 163 (1), 312-321, 1999 | 320 | 1999 |
Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism M Karbowniczek, A Astrinidis, BR Balsara, JR Testa, JH Lium, TV Colby, ... American journal of respiratory and critical care medicine 167 (7), 976-982, 2003 | 312 | 2003 |
Official American Thoracic Society/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management FX McCormack, N Gupta, GR Finlay, LR Young, AM Taveira-DaSilva, ... American journal of respiratory and critical care medicine 194 (6), 748-761, 2016 | 281 | 2016 |
Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis BW Kinder, KK Brown, FX McCormack, JH Ix, A Kervitsky, MI Schwarz, ... Chest 135 (6), 1557-1563, 2009 | 255 | 2009 |
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases LR Young, R VanDyke, PM Gulleman, Y Inoue, KK Brown, LS Schmidt, ... Chest 138 (3), 674-681, 2010 | 253 | 2010 |
120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. PE Zimmerman, DR Voelker, FX McCormack, JR Paulsrud, WJ Martin The Journal of clinical investigation 89 (1), 143-149, 1992 | 249 | 1992 |
Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications KF Almoosa, JH Ryu, J Mendez, JT Huggins, LR Young, EJ Sullivan, ... Chest 129 (5), 1274-1281, 2006 | 216 | 2006 |